These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7366815)

  • 21. Plasma-nortriptyline levels in endogenous depression.
    Kragh-Sørensen P; Asberg M; Eggert-Hansen C
    Lancet; 1973 Jan; 1(7795):113-5. PubMed ID: 4118463
    [No Abstract]   [Full Text] [Related]  

  • 22. The relationship between nortriptyline plasms levels and clinical effects.
    Kragh-Sorensen P
    Proc R Soc Med; 1975 Feb; 68(2):99-102. PubMed ID: 1101270
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetic aspects on once-daily nortriptyline administration.
    Overø KF
    Neuropsychobiology; 1980; 6(1):34-41. PubMed ID: 7366812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amitriptyline nortriptyline plasma levels and therapeutic response in depressed women.
    Corona GL; Fenoglio L; Pinelli P; Zerbi F
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Dec; 10(6):299-308. PubMed ID: 360244
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term treatment of endogenous depression with nortriptyline with control of plasma levels.
    Kragh-Sorensen P; Hansen CE; Larsen NE; Nasestoft J; Hvidberg EF
    Psychol Med; 1974 May; 4(2):174-80. PubMed ID: 4208380
    [No Abstract]   [Full Text] [Related]  

  • 26. The correlation of subjective side-effects with plasma concentrations of nortriptyline.
    Asberg M
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):20. PubMed ID: 5314406
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma nortriptyline and clinical response--a study using changing plasma levels.
    Burrows GD; Maguire KP; Scoggins BA; Stevenson J; Davies B
    Psychol Med; 1977 Feb; 7(1):87-91. PubMed ID: 870930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentration of nortriptyline and clinical response in depressive illness.
    Burrows GD; Davies B; Scoggins BA
    Lancet; 1972 Sep; 2(7778):619-23. PubMed ID: 4116775
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship between plasma level and therapeutic effect of nortriptyline.
    Asberg M; Crönholm B; Sjöqvist F; Tuck D
    Br Med J; 1971 Aug; 3(5770):331-4. PubMed ID: 5558186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relation of plasma amitriptyline and nortriptyline levels to the therapeutic response in endogenous depression].
    Garaj V; Frank V; Drímalová M; Móric R; Pullmann R
    Cesk Psychiatr; 1986 Oct; 82(5):307-12. PubMed ID: 3791462
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship between antidepressant effect and plasma level of nortriptyline. Clinical studies.
    Kragh-Søorensen P; Hansen CE; Baastrup PC
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):27-32. PubMed ID: 790409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma nortriptyline and clinical response.
    Burrows G; Scoggins BA; Turecek LR; Davies B
    Clin Pharmacol Ther; 1974 Oct; 16(4):639-44. PubMed ID: 4608523
    [No Abstract]   [Full Text] [Related]  

  • 33. Monitoring plasma concentration of nortriptyline. Methodological, pharmakokinetic and clinical aspects.
    Kragh-Sørensen P
    Dan Med Bull; 1985 Mar; 32(1):29-53. PubMed ID: 3886309
    [No Abstract]   [Full Text] [Related]  

  • 34. Saliva secretion following long-term antidepressant treatment with nortriptyline controlled by plasma levels.
    Bertram U; Kragh-Sørensen P; Rafaelsen OJ; Larsen NE
    Acta Psychiatr Scand Suppl; 1981; 290():357-63. PubMed ID: 6939317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of plasma levels of tricyclic antidepressant drugs in the treatment of depression.
    Lancet; 1973 Mar; 1(7802):556-8. PubMed ID: 4119995
    [No Abstract]   [Full Text] [Related]  

  • 36. Saliva secretion following long-term antidepressant treatment with nortriptyline controlled by plasma levels.
    Bertram U; Kragh-Sørensen P; Rafaelsen OJ; Larsen NE
    Scand J Dent Res; 1979 Feb; 87(1):58-64. PubMed ID: 284578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Connection between the kinetics and the therapeutic effects of tricyclic antidepressive agents. A review and results obtained with nortriptyline (Sensival)].
    Kragh-Sorensen P
    Ugeskr Laeger; 1972 Oct; 134(44):2309-14. PubMed ID: 5087288
    [No Abstract]   [Full Text] [Related]  

  • 38. Implications of dose regimen and protein binding for plasma nortriptyline estimations.
    Stevenson IH; Wilson NM; Schiff AA
    Neuropharmacology; 1978 Jun; 17(6):423-6. PubMed ID: 673158
    [No Abstract]   [Full Text] [Related]  

  • 39. Prediction of steady-state nortriptyline plasma levels by the repeated one-point method.
    Fant WK; Ritschel WA; Alwis SK; Roe S; Ehret J
    Clin Pharmacokinet; 1984; 9(5):450-6. PubMed ID: 6499343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of subjective side effects with plasma concentrations of nortriptyline.
    Asberg M; Cronholm B; Sjöqvist F; Tuck D
    Br Med J; 1970 Oct; 4(5726):18-21. PubMed ID: 5470429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.